Fig. 2From: Impact of fractionated stereotactic radiotherapy on activity of daily living and performance status in progressive/recurrent glioblastoma: a retrospective studya Median overall survival time from diagnosis. b Median overall survival time from reirradiation. c Median progression free survival time from reirradiation. d Median institutionalization free survival time from reirradiationBack to article page